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Introduction
Clostridium difficile-associated diarrhea (CDAD) 
is the most common cause of infectious diarrhea 
associated with exposure to healthcare settings. 
Amongst hospitalized patients, CDAD leads to 
prolonged stays, increased morbidity and mortal-
ity and increased healthcare costs [McDonald 
et al. 2012]. In a recent US survey, there were 
336,600 hospitalizations that involved a diagnosis 
of CDAD: nearly 1% of all hospital stays. In a 
time when the incidences of other healthcare-
associated infections are diminishing, CDAD is 
increasing with only a recent leveling off [Lucado 
et al. 2012]. Expenditures have also risen, with 
the current cost for CDAD healthcare in the 
United States averaging US$3.2 billion annually 
[O’Brien et al. 2007]. Hospitalized patients with 
CDAD, independent of age or comorbidity, are 
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Abstract 
Background: The incidence, recurrence, and all-cause mortality rate for Clostridium difficile-
associated diarrhea (CDAD) has increased markedly over the past 10 years despite treatment. 
Low vitamin D levels are known to impair immune responses to infection and are associated 
with increased mortality. We compared the role of patient comorbidity measured by the 
Charlson Comorbidity Index (CCI) with vitamin D levels to ascertain whether vitamin D levels 
were an independent variable affecting the outcome of CDAD or a marker of overall comorbidity.
Methods: A prospective cohort study studied 62 patients hospitalized between 2008 and 
2009 with manifestations of CDAD and a positive C. difficile toxin assay. All patients received 
standard antibiotics (metronidazole and/or vancomycin). Their status at 30-day follow up was 
classified as resolved or recurred/expired. Patients’ CCI was calculated using their medical 
history. Logistic regression analysis of variables including 25-hydroxyvitamin D, CCI, age, 
gender, white blood cell count (WBC), albumin and residence type were performed.
Results: There were 62 patients (43.6% men, 56.4% women) with CDAD; mean age was 75 ± 17 
years. At 30-day follow up, 28 (45.2%) expired, 10 (16.1%) had persistent or recurrent diarrhea 
and 24 (38.7%) resolved. Nonresolution was seen in 38 (61.3%). There was no significant 
association between 30-day resolution status and CCI, gender, WBC, albumin level or 
residence type. Two variables were found to be independent predictors of resolution of CDAD: 
normal vitamin D levels (p = 0.028) and age <70 years (p = 0.024). Subjects with low vitamin D 
were 4.75 times more likely to fail to resolve CDAD than subjects with normal Vitamin D.
Conclusion: In this study, vitamin D level and age are independent predictors of CDAD 
resolution in hospitalized patients. Low vitamin D levels and age >70 years old are associated 
with increased likelihood of recurrence. Low vitamin D levels are not a marker of comorbidity 
or advanced age.
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also 2.74-fold more likely to die during their hos-
pital stay than all other hospitalized patients 
[Wenisch et al. 2012].
Hypovitaminosis D is known to cause impaired 
innate and adaptive immune responses to infec-
tion [Hewison, 2012]. In a recent study, vitamin 
D deficiency was linked to adverse and more 
costly outcomes in veterans with C. difficile and 
methicillin-sensitive Staphylococcus aureus infec-
tions [Youssef et al. 2010]. Low vitamin D levels 
increases susceptibility to influenza [Cannell et al. 
2006], tuberculosis [Arnedo-Pena et al. 2011] 
and human immunodeficiency virus acquisition 
[Sanchez de la Torre et al. 2008; Talat et al. 2010]. 
Hypovitaminosis D is also associated with auto-
immune diseases—insulin-dependent diabetes 
mellitus, inflammatory bowel disease, multiple 
sclerosis and rheumatoid arthritis have all been 
implicated [Cantorna and Mahon, 2004]. 
Moreover, hypovitaminosis D has been associated 
with a higher risk of all-cause mortality in hospi-
talized patients [Melamed et al. 2008]. Previous 
reported risk factors that are associated with 
CDAD include severity of underlying illness, 
antibiotics usage, advanced age, prior hospitaliza-
tion, usage of proton pump inhibitors, gastroin-
testinal surgery, use of feeding tubes and 
retirement home residence [Vesteinsdottir et al. 
2012].
In view of the impact of hypovitaminosis D on the 
immune system, infectious disease and overall 
mortality, we sought to investigate the role of vita-
min D in CDAD. In a prospective cohort study, 
we measured vitamin D levels in all hospitalized 
patients diagnosed with CDAD to assess the 
impact of low vitamin D levels in CDAD resolu-
tion. We further sought to isolate vitamin D as an 
independent variable in CDAD resolution by cal-
culating the Charlson Comorbidity Index (CCI) 
in all patients.
Materials and methods
A prospective cohort study was performed on all 
patients hospitalized between May 2008 and June 
2009, with manifestations of CDAD and a posi-
tive C. difficile toxin assay. All patients received 
standard antibiotic treatment with metronidazole 
and/or vancomycin. Systemic antibiotic usage 
after discharge was not recorded. Demographic 
variables such as gender, age (dichotomized to 
<70 years old or >70 years old), residence (nurs-
ing facility or home) were examined. Baseline 
values of 25-hydroxyvitamin D, white blood cell 
count (WBC) and albumin were also collected. 
25-hydroxyvitamin D levels less than 21 ng/ml 
was considered to be low; while WBC greater 
than 20,000/µl was considered in the high range. 
Patients were followed at 30 days post-discharge 
by telephone survey. At the 30-day follow up, a 
patient was classified as having resolved, recurred 
or expired. A patient who had diarrhea at 30 days 
post-discharge or died, was considered ‘not 
resolved’.
To minimize comorbidity from obscuring the 
relationship between vitamin D and CDAD reso-
lution and improve internal validity of the study, 
each patient’s CCI and age-adjusted CCI was cal-
culated using their medical history. The CCI was 
developed in 1987 based on internal medicine 
patients admitted to a single New York hospital 
and their 1-year mortality rates. The index 
includes 19 medical conditions weighted as 1, 2, 3 
or 6 (Table 1). The weight was assigned based on 
the magnitude of the adjusted relative risks each 
comorbidity held in a Cox proportional hazards 
regression model [Charlson et al. 1987]. CCI has 
been compared with six other indices of comor-
bidity showing concurrent validity, as well as pre-
dictive validity for length of stay, mortality, 
disability and readmissions [De Groot et al. 
2003]. The weighted conditions provided a sum 
score to yield the total comorbidity score; which 
was adapted to account for increasing age. One 
point was further added for each ten year period, 
starting at the age of 50 years, and is added to 
previous comorbidity score.
The primary outcome variable is the status of the 
CDAD patient at 30 days post-discharge. Patient 
outcome was classified into two groups: expired/
recurred versus resolved. Expired was defined as 
mortality from any cause within the 30-day 
observation period. Differences between groups 
were assessed using the t-test or the Mann–
Whitney test, as appropriate, for continuous vari-
ables. For categorical variables, the chi-squared 
test or Fisher’s exact test was used accordingly. A 
multivariate logistic regression analysis was car-
ried out with 30-day status as the event of 
interest.
The following variables were used in the multi-
variate analysis: vitamin D status, gender, WBC 
(normal versus high), residence (nursing home 
versus home), age (years) and CCI. A backward 
elimination algorithm was applied in order to 
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determine which factors were most associated 
with the 30-day status. From the final model, 
adjusted odds ratios were estimated along with 
the corresponding 95% confidence intervals.
Results
A total of 62 patients completed the study with 
the gender distribution of 43.6% males and 
56.4% females. The mean age was 75 ± 17 years. 
Males were significantly younger than females 
(68.30 ± 17.61 versus 80.06 ± 15.36; p = 0.0023) 
(Table 2).
At 30-day follow up, 28 expired (45.2%), 10 
(16.1%) had persistent or recurrent diarrhea and 
24 (38.7%) resolved. In total 38 (61.3%) were 
not resolved. There was no significant association 
between 30-day resolution status and gender, 
WBC, type of residence and CCI. In addition, the 
mean albumin level in patients who resolved was 
2.91 versus 2.54 in patients who did not resolve 
(p = 0.064), which did not reach statistical signifi-
cance. However, there was a higher proportion of 
patients with low vitamin D levels who did not 
resolve as compared with those patients with nor-
mal vitamin D levels (71% versus 46%; p = 0.047).
Two variables were found to be independent pre-
dictors of resolution of CDAD, normal vitamin 
D levels (p = 0.028) and age (p = 0.024). Patients 
with low levels of vitamin D were 4.75 times 
more likely to recur or expire than patients with 
normal levels of Vitamin D (Table 3). In addi-
tion, with each additional year in age, patients 
were 1.06 times more likely to recur or expire 
(odds ratio [OR] = 1.06, 95% confidence inter-
val [CI] 1.01–1.11; p < 0.024). More practically, 
the OR for a 10-year increment in age was 1.8. 
Consequently, the odds of recurrence or death 
increases 80% (100 × (1.8 – 1)) for every 10-year 
increase in age, assuming all other variables 
remain constant.
Using a backward elimination algorithm we 
arrived at a more parsimonious model with only 
vitamin D status and age in the model (Table 4), 
where the odds of recurrence or death was 5.6 
times higher in subjects with low vitamin D levels 
than in subjects with normal vitamin D levels 
(OR = 5.6, 95% CI 1.5–21.1; p < 0.012) and for 
every 10-year increment in age, the odds of recur-
rence or death is 1.8 times higher (OR = 1.8, 95% 
CI 1.1–2.6; p < 0.008).
Table 1. List of comorbidities according to the 
Charlson Comorbidity Index score.
Condition Score
Myocardial Infarction 1
Congestive heart failure 1
Peripheral vascular disease 1
Cerebrovascular disease 1
Dementia 1
Chronic obstructive pulmonary disease 1
Connective tissue disease 1
Peptic ulcer disease 1
Mild liver disease 1
Diabetes 1
Hemiplegia 2
Moderate-severe renal disease 2
Diabetes with organ damage 2
Any tumor (within past 5 years) 2
Lymphoma 2
Leukemia 2
Moderate–severe liver disease 3
Metastatic solid tumor 6
AIDS 6
Table 2. Patient characteristics. Data are presented as mean ± standard deviation or n (%).
Variable Overall (n = 62) Men (n = 27) Women (n = 35) p-value
Age 74.94 ± 17.27 68.30 ± 17.61 80.06 ± 15.36 0.002
WBC 14.84 ± 9.16 15.35 ± 9.38 14.45 ± 9.10 0.435
Albumin 2.69 ± 0.74 2.70 ± 0.84 2.68 ± 0.66 0.917
25 hydroxyvitamin D 22.19 ± 25.85 18.44 ± 8.42 25.09 ± 33.54 0.680
CCI 2.56 ± 2.21 3.26 ± 2.49 2.03 ± 1.82 0.057
CCI - age adjusted 5.68 ± 2.65 5.70 ± 2.77 5.66 ± 2.59 0.737
Age (>70 years) 45 (72.6%) 16 (59.2%) 29 (82.9%) 0.04
Nursing Home 34 (58.6%) 13 (50%) 21 (65.6%) 0.23
CCI, Charlson Comorbidity Index; WBC, white blood cell count.
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Discussion
Our findings suggest that vitamin D level and age 
are independent predictors of CDAD resolution 
in hospitalized patients. We utilized the CCI to 
correct for comorbid conditions that may con-
found the relationship between vitamin D and 
CDAD resolution. In other words, low vitamin D 
is not simply a marker of comorbidity, but is in 
fact an independent predictor of poor outcomes 
in CDAD patients. Patients with hypovitaminosis 
D had a nearly five times greater likelihood of 
nonresolution of CDAD than patients with nor-
mal vitamin D levels. Older patients aged 70 years 
or higher, were also found to be less likely to have 
CDAD resolution.
There is a high rate of recurrent disease following 
treatment with metronidazole or vancomycin 
(20.2% and 18.4%, respectively) [Kelly and 
LaMont, 2008]. Utilization of either medication 
impairs resistance to colonization, thereby facili-
tating recurrent infections, which is seen within 4 
weeks after therapy completion. Recurrence can 
be due to persistence of the strain responsible for 
the initial episode or reinfection with a different 
strain of C. difficile [Wilcox et al. 1998]. Host 
immunity plays a role, as there is a dramatic esca-
lation of risk of recurrence in patients who have 
already had one recurrence. The recurrence risk 
rises from around 20% after an initial episode, to 
about 40% after a first recurrence and to over 
60% with two or more recurrences [Kelly and 
LaMont, 2008]. Previous studies have identified 
various risk factors for recurrent disease; these 
include persistence of spores possibly in colonic 
diverticula [McFarland et al. 2002], continuation 
of systemic antibiotics [Alfa et al. 1999], lower 
reported quality-of-health [McFarland et al. 
1999] and colonization with vancomycin-resist-
ant enterococci [Choi et al. 2011]. This is the first 
study to date that has identified a link between low 
vitamin D levels and failure to resolve C. difficile 
enteritis. By assessing the CCI in all patients, we 
were also able to demonstrate that poor outcomes 
in patients with low vitamin D are not secondary 
to pre-existing comorbidity. Rather, vitamin D 
appears to be an independent factor, possibly 
relating to its role in host immunity [Hewison, 
2012]. The only other independent predictor of 
poor outcome in this study was advanced age 
(>70 years old).
One of the limitations of this study is its relatively 
small sample size. In addition, patients were con-
sidered resolved based on their history obtained 
via a telephone survey, and no follow-up stool 
studies were performed. Another limitation is the 
high mortality rate in this cohort of hospitalized 
patients with multiple comorbidities. As the study 
interval was only 30 days, long-term antibiotic 
Table 3. Logistic regression for 30-day status (recurred/expired versus resolved).
Covariates in the model Adjusted odds ratio (95% CI) p-value
Vitamin D group (low versus normal) 4.75 (1.18–19.1) 0.028
Gender (male versus female) 0.60 (0.16–2.35) 0.468
WBC group (normal versus high) 2.18 (0.40–11.78) 0.363
Residence (nursing home versus home) 0.59 (0.15–2.28) 0.444
Age (years) 1.06 (1.01–1.11) 0.024
CCI 1.16 (0.86–1.56) 0.318
c-statistic = 0.776
CI, confidence interval; CCI, Charlson Comorbidity Index; WBC, white blood cell count.
Table 4. Logistic regression for 30-day status (recurred/expired versus resolved): reduced model after 
backward elimination.
Covariates in the Model Adjusted odds ratio (95% CI) p-value
Vitamin D group (low versus normal) 5.6 (1.49, 21.12) 0.011
Age (years) 1.06 (1.01, 1.11) 0.008
c-statistic = 0.754
CI, confidence interval.
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usage was not tracked. In addition, the number of 
patients on immunosuppressant drugs was too 
small to be included in this study. Furthermore, 
we categorized patients who died as nonresolu-
tion. This may have led to an overestimation of 
failure to resolve C. difficile as the exact cause of 
mortality in each patient is unknown. In fact, high 
all-cause mortality in hospitalized patients with 
low vitamin D levels have already been reported, 
and are likely due to factors other than the effects 
of low vitamin D levels on CDAD [Melamed et al. 
2008]. Nevertheless, our data adds to a growing 
literature of the adverse outcomes of hypovita-
minosis D in hospitalized patients with serious ill-
nesses such as CDAD.
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